It wasn’t an obvious day to climb the Eiffel Tower. It was the end of November, 1989. Overcast and cold, with clouds ...

Scientists in Europe have identified a previously unknown species of fungus that turns cave spiders into “zombies.” The fungus lures them out of their webs before instigating an untimely death and ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

Blood testing of large-animal veterinarians suggests that H5N1 bird flu has spread more widely than US surveillance of the virus is capturing, according to a new study by federal and state disease ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

PRINCETON, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company” or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic ...

With millions sipping their morning coffee to start the day, recent research has generated new buzz about caffeine ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting ...

FY 2024 total sales growth of 9.9% at CER1, or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including ...

The issuer is solely responsible for the content of this announcement.